Vimarsana
Biggest News Aggregation in the World

Page 12 - Pfizer Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pfizer Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pfizer Ventures Today - Breaking & Trending Today

Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing to decode the dark matter of the human genome and deliver first-in-class precision medicines - Vimarsana News

Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing to decode the dark matter of the human genome and deliver first-in-class precision medicines

Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing to decode the dark matter of the human genome and deliver first-in-class precision medicines - read this article along with other careers information, tips and advice on BioSpace

STORM Therapeutics to present new data on its lead program STC-15 at the 34th EORTC-NCI-AACR Symposium and the 37th SITC Meeting - Vimarsana News

STORM Therapeutics to present new data on its lead program STC-15 at the 34th EORTC-NCI-AACR Symposium and the 37th SITC Meeting

/PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modifying...

Nucleome Therapeutics Raises £37.5M in Series A Financing - Vimarsana News

Nucleome Therapeutics Raises £37.5M in Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Nipping Alzheimer's disease in the blood | 93.1 Coast Country - Vimarsana News

Nipping Alzheimer's disease in the blood | 93.1 Coast Country

KINGSTON, RI – MindImmune, a drug discovery firm, working in collaboration with the George & Anne Ryan Institute for Neuroscience at the University of Rhode Island, recently completed a $12.4 million Series A round of financing.The firm is be...

Anjarium Biosciences Appoints Gaurav Shah as Chairperson and Douglas Fambrough as Non-executive Director - Vimarsana News

Anjarium Biosciences Appoints Gaurav Shah as Chairperson and Douglas Fambrough as Non-executive Director

Board expansion brings significant additional gene therapy and corporate development expertise to AnjariumZURICH, Oct. 18, 2022 /PRNewswire/ -- Anjarium Biosciences AG ("Anjarium"), a biotech